Follow Us On
Tablets
Files
Emtricitabine and Tenofovir Disoproxil Fumarate
Strength: 200mg/300mg
Count: 30
NDC
42291-980-30
Class
Rx
Brand Name
Truvada
Imprint Code
TV;C75
Color(s)
WHITE (white to off-white)
Shape
Oval (capsule shaped)
Score
No Score
Case Count
NA
Inactive Ingredients
crospovidone, lactose monohydrate, magnesium stearate, mannitol, polyethylene glycol, polyvinyl alcohol, povidone, talc, and titanium dioxide
Indications and Usage
1.1 Treatment of HIV-1 Infection Emtricitabine and tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17 kg. 1.2 HIV-1 Pre-Exposure Prophylaxis (PrEP) Emtricitabine and tenofovir disoproxil fumarate tablets are indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test immediately prior to initiating emtricitabine and tenofovir disoproxil fumarate tablets for HIV-1 PrEP.
